Better Therapeutics Correlations
The correlation of Better Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Better |
The ability to find closely correlated positions to Better Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Better Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Better Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Better Therapeutics to buy it.
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Better OTC Stock performing well and Better Therapeutics OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Better Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ABVC | 4.07 | 0.58 | 0.11 | (4.03) | 4.50 | 9.80 | 32.39 | |||
| INDP | 3.17 | (0.29) | 0.00 | 1.49 | 0.00 | 6.32 | 20.25 | |||
| KTTA | 5.18 | (1.04) | 0.00 | 1.03 | 0.00 | 8.14 | 53.63 | |||
| FBRX | 5.58 | (1.22) | 0.00 | (1.05) | 0.00 | 9.14 | 28.46 | |||
| AVTE | 1.29 | 0.02 | 0.04 | 0.00 | 1.52 | 2.07 | 10.45 | |||
| ADAG | 2.52 | (0.32) | 0.00 | 0.26 | 0.00 | 4.04 | 18.68 | |||
| ACRV | 4.13 | (0.16) | 0.00 | (0.16) | 0.00 | 10.17 | 30.57 | |||
| RZLT | 3.07 | (0.48) | 0.00 | (0.58) | 0.00 | 5.62 | 22.04 | |||
| ANTX | 2.37 | 0.11 | 0.05 | 0.12 | 2.47 | 5.41 | 17.09 | |||
| SABSW | 19.43 | 2.83 | 0.13 | 12.39 | 18.20 | 50.19 | 214.55 |
View Better Therapeutics Related Equities
| Risk & Return | Correlation |
Better Therapeutics Corporate Management
Elected by the shareholders, the Better Therapeutics' board of directors comprises two types of representatives: Better Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Better. The board's role is to monitor Better Therapeutics' management team and ensure that shareholders' interests are well served. Better Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Better Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thiago Oliveira | Chief Officer | Profile | |
| Angela Willis | Senior Access | Profile | |
| Kevin Appelbaum | CoFounder Director | Profile | |
| Jessica Meng | Chief Officer | Profile | |
| Mark MD | Chief Officer | Profile | |
| Mark Heinen | Head CFO | Profile |
Still Interested in Better Therapeutics?
Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.